Pharmafile.com’s weekly COVID-19 news round-up
pharmafile | August 26, 2020 | News story | Research and Development |Â Â COVID, COVID-19, coronavirusÂ
In COVID-19 news this week, China is set to move ahead with human testing of a potential coronavirus vaccine that has been created using insect cells while Australia has signed its first deal to secure doses of a potential vaccine for its citizens, inking a partnership with AstraZeneca and the University of Oxford.
In treatment related news, the FDA could expand its Emergency Use Authorization (EUA) for Gilead’s remdesivir for treating coronavirus patients while AstraZeneca has started a clinical trial of its antibody treatment designed to prevent and also treat symptoms of the virus.
1. AstraZeneca begins antibody COVID-19 treatment trial in the UK – Published on 25/08/20
AstraZeneca has started a clinical trial of its antibody treatment designed to prevent and also treat symptoms of coronavirus.
2. China’s ‘insect’ vaccine for COVID-19 approved for human testing – Published on 24/08/20
China is set to move ahead with human testing of a potential coronavirus vaccine that has been created using insect cells.
3. Gilead says FDA could expand eligibility of coronavirus patients for remdesivir – Published on 24/08/20
The FDA could expand its Emergency Use Authorization (EUA) for Gilead’s remdesivir for treating coronavirus patients, according to Gilead.
4. Australia signs first COVID-19 vaccine deal for 25 million doses of AstraZeneca/Oxford University candidate – Published on 19/08/20
Australia has signed its first deal to secure doses of a potential COVID-19 vaccine for its citizens, inking a partnership with AstraZeneca and the University of Oxford for their jointly developed candidate known as ChAdOx1.
5. UK Government officially announces National Institute for Health Protection to replace Public Health England – Published 19/08/20
The UK Government has officially announced that Public Health England will be replaced by the National Institute for Health Protection.
Related Content
COVID-19 vaccine eligibility creates challenges for UK pharmacies
Pharmacists across England have reported widespread confusion among patients attempting to book COVID-19 vaccination appointments …
Mental health medicine use in England reaches record high, NHSBSA report reveals
According to new data published by the NHS Business Services Authority (NHSBSA), mental health prescriptions …
FDA approves Moderna’s Spikevax for children at increased risk of COVID-19
Moderna has been granted US Food and Drug Administration (FDA) approval for its COVID-19 vaccine, …
